MITOCHONDRIAL DISEASE TRIAL: Dec 1, 2020 15:30 UTC TOKYO–(Business Wire)–LUCA Science (Tokyo, Japan), a biotechnology company pioneering a novel class of mitochondrial therapeutics, announced today that it will collaborate with the Division of Cardiology, Field of Internal Medicine, Nagoya University Graduate School of Medicine to initiate a joint research on the development […]
Click here to view original web page at www.digitaljournal.com